| Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1838 | 2020 |
| Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism MF Paine, M Khalighi, JM Fisher, DD Shen, KL Kunze, CL Marsh, ... Journal of Pharmacology and Experimental Therapeutics 283 (3), 1552-1562, 1997 | 1030 | 1997 |
| First‐pass metabolism of midazolam by the human intestine MF Paine, DD Shen, KL Kunze, JD Perkins, CL Marsh, JP McVicar, ... Clinical Pharmacology & Therapeutics 60 (1), 14-24, 1996 | 635 | 1996 |
| Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients. KE Thummel, DD Shen, TD Podoll, KL Kunze, WF Trager, PS Hartwell, ... Journal of Pharmacology and Experimental Therapeutics 271 (1), 549-556, 1994 | 422 | 1994 |
| Survival benefit with kidney transplants from HLA-incompatible live donors BJ Orandi, X Luo, AB Massie, JM Garonzik-Wang, BE Lonze, R Ahmed, ... New England Journal of Medicine 374 (10), 940-950, 2016 | 378 | 2016 |
| Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro Y Dai, MF Hebert, N Isoherranen, CL Davis, C Marsh, DD Shen, ... Drug metabolism and disposition 34 (5), 836-847, 2006 | 377 | 2006 |
| Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter-and intraindividual hepatic CYP3A variability after liver transplantation. KE Thummel, DD Shen, TD Podoll, KL Kunze, WF Trager, CE Bacchi, ... Journal of Pharmacology and Experimental Therapeutics 271 (1), 557-566, 1994 | 286 | 1994 |
| Quantitation of BK virus load in serum for the diagnosis of BK virus–associated nephropathy in renal transplant recipients AP Limaye, KR Jerome, CS Kuhr, J Ferrenberg, ML Huang, CL Davis, ... The Journal of infectious diseases 183 (11), 1669-1672, 2001 | 235 | 2001 |
| Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial JF Markmann, MS Abouljoud, RM Ghobrial, CS Bhati, SJ Pelletier, AD Lu, ... JAMA surgery 157 (3), 189-198, 2022 | 202 | 2022 |
| Quantifying the risk of incompatible kidney transplantation: a multicenter study BJ Orandi, JM Garonzik‐Wang, AB Massie, AA Zachary, JR Montgomery, ... American Journal of Transplantation 14 (7), 1573-1580, 2014 | 201 | 2014 |
| Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study F Steinbach, AC Novick, H Zincke, DP Miller, RD Williams, G Lund, ... The Journal of urology 153 (6), 1812-1816, 1995 | 200 | 1995 |
| A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1 RWG Gruessner, GW Burke, R Stratta, H Sollinger, E Benedetti, C Marsh, ... Transplantation 61 (2), 261-273, 1996 | 174 | 1996 |
| Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use KD Smith, LE Wrenshall, RF Nicosia, R Pichler, CL Marsh, CE Alpers, ... Journal of the American Society of Nephrology 14 (4), 1037-1045, 2003 | 172 | 2003 |
| Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers MF Hebert, RM Fisher, CL Marsh, D Dressler, I Bekersky The Journal of Clinical Pharmacology 39 (1), 91-96, 1999 | 165 | 1999 |
| Inhibitory effects of immunosuppressive drugs on insulin secretion from hit-T15 cells and Wistar rat islets1 BW Paty, JS Harmon, CL Marsh, RP Robertson Transplantation 73 (3), 353-357, 2002 | 161 | 2002 |
| Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling SM Kurian, AN Williams, T Gelbart, D Campbell, TS Mondala, SR Head, ... American Journal of Transplantation 14 (5), 1164-1172, 2014 | 129 | 2014 |
| Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. CL Davis, KL Harrison, JP McVicar, PJ Forg, MP Bronner, CL Marsh Clinical transplantation 9 (1), 53-59, 1995 | 126 | 1995 |
| Superiority of intralesional immunotherapy with Corynebacterium parvum and Allium sativum in control of murine transitional cell carcinoma BHS Lau, JL Woolley, CL Marsh, GR Barker, DH Koobs, RR Torrey The Journal of urology 136 (3), 701-705, 1986 | 117 | 1986 |
| Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized … WH Marks, N Mamode, RA Montgomery, MD Stegall, LE Ratner, ... American Journal of Transplantation 19 (10), 2876-2888, 2019 | 115 | 2019 |
| Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors MF Hebert, ALS Dowling, C Gierwatowski, YS Lin, KL Edwards, CL Davis, ... Pharmacogenetics and Genomics 13 (11), 661-674, 2003 | 114 | 2003 |
